Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II trial of pembrolizumab, ipilimumab, and aspirin in melanoma: clinical outcomes and translational predictors of response.
Quandt Z, Jacob S, Fadlullah MZH, Wu C, Wu C, Huppert L, Levine LS, Sison P, Tsai KK, Chow M, Kang JH, Hwang J, Lee JC, Oglesby A, Venegas J, Brintz BJ, Tan AC, Anderson MS, Rosenblum MD, Young A, Daud AI. Quandt Z, et al. Among authors: daud ai. BJC Rep. 2024 Jun 24;2(1):46. doi: 10.1038/s44276-024-00057-7. BJC Rep. 2024. PMID: 39516257 Free PMC article.
Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma.
Levine LS, Mahuron KM, Tsai KK, Wu C, Mattis DM, Pauli ML, Oglesby A, Lee JC, Spitzer MH, Krummel MF, Algazi AP, Rosenblum MD, Alvarado M, Daud AI. Levine LS, et al. Among authors: daud ai. Ann Surg Oncol. 2020 Oct;27(11):4122-4130. doi: 10.1245/s10434-020-08648-7. Epub 2020 Jun 2. Ann Surg Oncol. 2020. PMID: 32488521 Free PMC article.
Intratumoral therapies and in-situ vaccination for melanoma.
Huppert LA, Daud AI. Huppert LA, et al. Among authors: daud ai. Hum Vaccin Immunother. 2022 May 31;18(3):1890512. doi: 10.1080/21645515.2021.1890512. Hum Vaccin Immunother. 2022. PMID: 35559766 Free PMC article. Review.
PD-1 and PD-L1 antibodies for melanoma.
Tsai KK, Zarzoso I, Daud AI. Tsai KK, et al. Among authors: daud ai. Hum Vaccin Immunother. 2014;10(11):3111-6. doi: 10.4161/21645515.2014.983409. Hum Vaccin Immunother. 2014. PMID: 25625924 Free PMC article. Review.
Partially exhausted tumor-infiltrating lymphocytes predict response to combination immunotherapy.
Loo K, Tsai KK, Mahuron K, Liu J, Pauli ML, Sandoval PM, Nosrati A, Lee J, Chen L, Hwang J, Levine LS, Krummel MF, Algazi AP, Pampaloni M, Alvarado MD, Rosenblum MD, Daud AI. Loo K, et al. Among authors: daud ai. JCI Insight. 2017 Jul 20;2(14):e93433. doi: 10.1172/jci.insight.93433. eCollection 2017 Jul 20. JCI Insight. 2017. PMID: 28724802 Free PMC article.
Prognostic Biomarkers for Melanoma Immunotherapy.
Twitty CG, Huppert LA, Daud AI. Twitty CG, et al. Among authors: daud ai. Curr Oncol Rep. 2020 Feb 11;22(3):25. doi: 10.1007/s11912-020-0886-z. Curr Oncol Rep. 2020. PMID: 32048065 Review.
188 results